BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37053028)

  • 1. Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.
    Tsukamoto S; Aiba H; Righi A; Nitta Y; Traversari M; Mavrogenis AF; Honoki K; Tanaka Y; Donati DM; Errani C
    J Surg Oncol; 2023 Aug; 128(2):350-358. PubMed ID: 37053028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.
    Tang H; Moro A; Feng W; Lai Y; Xiao Z; Liu Y; Wang K
    J Surg Oncol; 2019 Sep; 120(3):359-365. PubMed ID: 31219620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
    Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
    Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.
    He Y; Guo J; Ding X; van Ooijen PMA; Zhang Y; Chen A; Oudkerk M; Xie X
    Eur Radiol; 2019 Oct; 29(10):5441-5451. PubMed ID: 30859281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
    Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneurysmal bone cyst and giant cell tumor of bone of the hand and distal radius.
    Athanasian EA
    Hand Clin; 2004 Aug; 20(3):269-81, vi. PubMed ID: 15275686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
    He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
    J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint.
    He Y; Wang J; Zhang J; Yuan F; Ding X
    Radiol Med; 2017 Jul; 122(7):546-555. PubMed ID: 28271359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.
    Urakawa H; Yonemoto T; Matsumoto S; Takagi T; Asanuma K; Watanuki M; Takemoto A; Naka N; Matsumoto Y; Kawai A; Kunisada T; Kubo T; Emori M; Hiraga H; Hatano H; Tsukushi S; Nishida Y; Akisue T; Morii T; Takahashi M; Nagano A; Yoshikawa H; Sato K; Kawano M; Hiraoka K; Tanaka K; Iwamoto Y; Ozaki T
    World J Surg Oncol; 2018 Aug; 16(1):160. PubMed ID: 30089488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
    Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage.
    Zhou L; Zhu H; Lin S; Jin H; Zhang Z; Dong Y; Yang Q; Zhang C; Yuan T
    Int Orthop; 2022 Feb; 46(2):381-390. PubMed ID: 34783889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
    Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
    Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huge aneurysmal bone cyst secondary to giant cell tumor of the hand phalanx: a case report and related literature.
    Li M; Gan Y; Shi D; Zhao J
    BMC Cancer; 2020 Mar; 20(1):233. PubMed ID: 32192464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroblastoma of the patella with secondary aneurysmal bone cyst, an easily misdiagnosed bone tumor:a case report with literature review.
    Zheng J; Niu N; Shi J; Zhang X; Zhu X; Wang J; Liu C
    BMC Musculoskelet Disord; 2021 Apr; 22(1):381. PubMed ID: 33892701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation.
    Tsukamoto S; Hindiskere S; Honoki K; Mavrogenis AF; Tanaka Y; Chinder PS; Donati DM; Errani C
    Int Orthop; 2023 Jan; 47(1):265-273. PubMed ID: 36282294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
    Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
    BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage.
    Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Zhang WB; Lu Y
    Radiol Med; 2014 Nov; 119(11):861-70. PubMed ID: 24604549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.